I. INTRODUCTION

The Relevance of Genetics to Medicine
This issue of the MCV Quarterly focuses on the
explosion of knowledge in the field of human genetics. The activities of the new Department of Human
Genetics at the Medical College of Virginia encompass the traditional medical school triad of teaching,
patient care, and research, and an active graduate
program has been developed with curricula leading
to masters a nd doctorate degrees. The program is
supported by a recently awarded National Institutes
of Health predoctoral training grant as well as State
and local funds from the A. D. Williams Foundation.
Clinical services are provided in a National
Foundation-March of Dimes Genetic Counseling
Clinic and through an interdepartmental Antenatal
Diagnosis Program . At present, however, as shown
by some of the case reports in this issue, resea rch and
clinical service a re inextricably intertwined.
There has, perhaps, been no recent advance in
medical technology that has greater potential for improving the human condition than the development
of reliable methods for the prenatal diagnosis of a
growing list of specific genetic diseases. The Antenatal Diagnosis Program at MCV has been developed with suppport from the State Department of
Health and has at its disposal the most modern"
equipment available for these test procedures. N eona ta I screening for genetic disease and carrier detection programs are two logical complements to prenatal diagnosis.
It is becoming increasingly clear that the major
causes of morbidity and mortality in Western cultures are neither entirely environmental nor genetic
in etiology but result, rather, from an interaction between the host and a pathogenic agent in a constantly
changing environment. The concept of genetic risk
factors may well emerge as the most significant and
effective new health care strategy to appear during
the last quarter of this century. Experience with the
treatment of genetically determined metabolic diseases suggests that when a specific genetic liability
can be diagnosed, patients and their parents are in

general highly motivated to comply even with extremely elaborate treatment regimes. Wouldn't a n
individual who had seen a parent or close relative die
of hypertension, heart disease, cancer, or pulmonary
disease have a strong motivation to comply with a
program of presymptomatic screening and treatment
if he or she could be shown to carry a specific genetic
risk factor? Improved public education will be essential for the acceptance of this approach to disease
prevention. Since all norma l individuals carry abnormal recessive genes, the diagnosis of a genetic disease
or carrier state in a family should not be viewed as a
stigma but rather as a readily identifiable risk factor
that can be exploited by the prudent physician to plan
a highly individualized health maintenance program
for the patient. At present, relatively few alleles have
been identified which can be detected in the heterozygous state that are associated with an increased
disease risk; however, the number is growing, and it
seems likely that this will continue to be a very active
area of research in the future.
Genetic diseases are estimated to acco unt for
15% of all pediatric hospital admissions. Recognizable chromosome abnormalities accou nt for more
than 50% of all early spontaneous first trimester abortions. A single genetic disease, Usher syn drome, accounts for more than 60% of all adults seeking rehabilitative services for the combined handicap of
deafness and blindness. The lifetime cost of caring for
the 3,000 to 4,000 new children who a re born each
year with Down syndrome is estimated to be in excess
of $60,000,000 per year. More than 2,000 genetic diseases have now been described, most within the past
two decades, and at least one genetic locus has now
been mapped to each of the 23 pairs of chromosomes,
most within the past two years. These facts presage
the increasingly important role that genetics will play
in medicine an d human affairs in future years.
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